Fran Gregory, PharmD, MBA, is the vice president of emerging therapies at Cardinal Health.
Real-World Data Crucial to Prove the Value of Expensive Cell and Gene Therapies: Fran Gregory, PharmD
As the number of cell and gene therapies expands, it's increasingly important for long-term patient data, explained Fran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health.